Aisling Capital

Aisling Capital is a private equity firm specializing in investments within the healthcare sector, focusing on companies that are developing and commercializing innovative products, services, and technologies. Since its inception in 2000, the firm has raised over $1.8 billion in committed capital across multiple funds, demonstrating a strong track record in the industry. Aisling Capital's team comprises professionals with extensive experience in clinical, operational, and financial aspects of healthcare, enabling them to effectively identify and execute investments across the life sciences industry.

The firm's investment strategy is centered on identifying differentiated healthcare products, services, and technologies that address unmet medical needs. Aisling Capital provides meaningful capital resources and strategic assistance to promising companies, aiming to enhance their growth opportunities. The firm invests across various stages, including seed and venture financings of development-stage companies, small-cap publicly traded equities, structured debt and royalty deals, and large-cap leveraged buyouts of profitable companies.

Aisling Capital takes an active approach to investing, working closely with portfolio companies to help them become value-building enterprises with multiple opportunities for exit. The investment professionals collaborate with management teams, contributing expertise and experience to help determine and execute strategy, identify and evaluate business opportunities, and address financial issues. This hands-on approach underscores Aisling Capital's commitment to the success and growth of its portfolio companies.